FIELD: chemistry.
SUBSTANCE: present invention relates to different halichondrin B analogues, in a crystalline form, having anticancer activity, as well as a method of producing compounds E-086526 or E-7389 of formulae: 
EFFECT: obtaining halichondrin analogues, having anticancer activity.
8 cl, 21 dwg, 11 tbl, 7 ex
или - or
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTAL COMPOUNDS | 2016 |
|
RU2789672C2 |
| CRYSTALLINE FORM OF GLYCOPYRRONIUM CHLORIDE | 2011 |
|
RU2569852C2 |
| CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]BENZOIC ACID, AND USE THEREOF AND METHODS FOR PREPARING | 2007 |
|
RU2474577C2 |
| DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM | 2010 |
|
RU2578956C2 |
| SOLID FORMS CONTAINING (-)-O-DESMETHYLVENLAFAXINE AND USE THEREOF | 2008 |
|
RU2477269C2 |
| NEW POLYMORPH | 2011 |
|
RU2559633C2 |
| CRYSTALLINE FORMS OF DISODIUM SALT OF N-(5-CHLOROSALICILOUL-)-8-AMINOCAPRYLIC ACID | 2006 |
|
RU2507196C2 |
| POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION AND PHARMACEUTICAL USES THEREOF | 2014 |
|
RU2658009C2 |
| METHOD OF PRODUCING CRYSTALLINE FORM OF HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | 2020 |
|
RU2823673C1 |
| ROMIDEPSIN SOLID FORMS AND USE THEREOF | 2011 |
|
RU2607634C2 |
